MANE · Veradermics, Inc
$101.81
-0.99 (-0.96%)
At close · Aug 27
Going-concern doubt
— cleared Aug 11, 2026
The latest filing no longer states the doubt (first flagged May 12, 2026).
View the 10-Q filed Aug 11, 2026Market Cap
$4.25B
Shares
41.78M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-07-15 | Study ‘207’ Phase 2 Clinical Trial Results of VDPHL01 in Females | Earnings call |
| 2026-06-24 | Expert Discussion + CEO Q&A on VDPHL01 in Pattern Hair Loss (Citi) | Event |
| 2026-06-08 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-06-03 | Jefferies Global Healthcare Conference | Conference |
| 2026-04-27 | Study 302 Phase 2/3 Topline Results | Event |
| 2026-03-10 | Leerink Partners Global Healthcare Conference | Conference |
Source: https://ir.veradermics.com/
Key facts
CIK
1827635
CUSIP
922967104
13F (30d)
154 filings
152 filers
Visit website
Investor relations